Relapsed plasmablastic lymphoma in a HIV-negative patient: Pushing the envelope

Manthan Kathrotiya1, Vivek S Radhakrishnan1, Saurabh J Bhave1

  • 1Clinical Haematology Oncology and HCT Tata Medical Center Kolkata India.

Clinical Case Reports
|February 18, 2021
PubMed

This case emphasizes that, with the availability of novel immunotherapy agents (Daratumumab), and repurposed use of bortezomib, a patient with HIV-negative relapsed PBL can be treated successfully and consolidated with an allogeneic haploidentical hematopoietic cell transplantation.